Vyome Holdings Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: HIND
Share price (3/27/26): $2.13
Market cap (3/27/26): $14.9 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 1 page Amendment to Asset Purchase Agreement

from S-4 83 pages Agreement and Plan of Merger by and Among ReShape Lifesciences Inc., Raider Lifesciences Inc., and Vyome Therapeutics, Inc. Dated July 8, 2024

from 8-K 36 pages Asset Purchase Agreement

from 425 36 pages Asset Purchase Agreement

from 425 83 pages Agreement and Plan of Merger by and Among ReShape Lifesciences Inc., Raider Lifesciences Inc., and Vyome Therapeutics, Inc. Dated July 8, 2024

from 8-K 83 pages Agreement and Plan of Merger by and Among ReShape Lifesciences Inc., Raider Lifesciences Inc., and Vyome Therapeutics, Inc. Dated July 8, 2024

from 8-K 78 pages Agreement and Plan of Merger by and Among Obalon Therapeutics, Inc., Optimus Merger Sub, Inc., and ReShape Lifesciences Inc. Dated January 19, 2021

from 425 78 pages Agreement and Plan of Merger by and Among Obalon Therapeutics, Inc., Optimus Merger Sub, Inc., and ReShape Lifesciences Inc. Dated January 19, 2021

from 425 78 pages Agreement and Plan of Merger by and Among Obalon Therapeutics, Inc., Optimus Merger Sub, Inc., and ReShape Lifesciences Inc. Dated January 19, 2021